34
Views
43
CrossRef citations to date
0
Altmetric
Research Article

Multicenter evaluation of the phosphorylcholinecoated biodivYsio stent in short de novo coronary lesions: The SOPHOS study

, , , , , , , , , , , , , , , , , , & show all
Pages 215-225 | Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

David E Kandzari. (2010) Development and performance of the zotarolimus-eluting Endeavor® coronary stent. Expert Review of Medical Devices 7:4, pages 449-459.
Read now
G. Sydow-Plum & M. Tabrizian. (2008) Review of stent coating strategies: clinical insights. Materials Science and Technology 24:9, pages 1127-1143.
Read now

Articles from other publishers (41)

Megan Douglass, Mark Garren, Ryan Devine, Arnab Mondal & Hitesh Handa. (2022) Bio-inspired hemocompatible surface modifications for biomedical applications. Progress in Materials Science 130, pages 100997.
Crossref
Taku Asano, Pannipa Suwannasom, Yuki Katagiri, Yosuke Miyazaki, Yohei Sotomi, Robin P. Kraak, Joanna Wykrzykowska, Benno J. Rensing, Jan J. Piek, Mariann Gyöngyösi, Patrick W. Serruys & Yoshinobu Onuma. (2018) First-in-Man Trial of SiO<sub>2</sub> Inert-Coated Bare Metal Stent System in Native Coronary Stenosis ― The AXETIS FIM Trial ―. Circulation Journal 82:2, pages 477-485.
Crossref
Andžela Šešok. 2017. Biomedžiagos: teorija ir praktika. Biomedžiagos: teorija ir praktika.
Masayuki Kyomoto, Toru Moro & Kazuhiko Ishihara. 2015. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials 330 355 .
K. Udipi. 2016. Biosynthetic Polymers for Medical Applications. Biosynthetic Polymers for Medical Applications 145 169 .
Masayuki Kyomoto, Toru Moro & Kazuhiko Ishihara. 2016. UHMWPE Biomaterials Handbook. UHMWPE Biomaterials Handbook 352 368 .
Lise Nadine Tchouta & Pramod Narayan Bonde. (2015) The Quest for Nonthrombotic Surface Modifications to Achieve Hemocompatibility of Implantable Devices. ASAIO Journal 61:6, pages 623-634.
Crossref
Kazuhiko Ishihara. (2015) Highly lubricated polymer interfaces for advanced artificial hip joints through biomimetic design. Polymer Journal 47:9, pages 585-597.
Crossref
Noemi Pavo, Bonni Syeda, Andreas Bernhart, Eszter Szentirmai, Rayyan Hemetsberger, Eslam Samaha, Christian Plass, Katrin Zlabinger, Imre J. Pavo, Zsolt Petrasi, Örs Petnehazy, Simon P. Hoerstrup, Gerald Maurer & Mariann Gyöngyösi. (2015) Preclinical randomised safety, efficacy and physiologic study of the silicon dioxide inert-coated Axetis and bare metal stent: short-, mid- and long-term outcome. EuroIntervention 11:4, pages 433-441.
Crossref
Katrin Sternberg, Raila Busch & Svea Petersen. 2015. Advanced Polymers in Medicine. Advanced Polymers in Medicine 433 480 .
William A. Gray, Alan C. Yeung, Donald E. Cutlip, Jeffrey J. Popma, Peter J. Fitzgerald, David O. Williams, Hubertus Heuer, Charles D. O'Shaughnessy, Paul A. Overlie, J. Tift Mann, Louis A. Cannon, James B. Hermiller, Timothy D. Henry, Robert Whitbourn, Thomas D. Stuckey, Mark G. Midei, Jessie Coe & Lewis B. Schwartz. (2012) A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: Final results of the ZoMaxx II trial. International Journal of Cardiology 157:1, pages 96-101.
Crossref
Andrew L. Lewis & Andrew W. Lloyd. 2012. Biomimetic, Bioresponsive, and Bioactive Materials. Biomimetic, Bioresponsive, and Bioactive Materials 95 140 .
M. Driver. 2012. Coatings for Biomedical Applications. Coatings for Biomedical Applications 223 250 .
Pascal Vranckx, Eric Boersma, Scot Garg, Marco Valgimigli, Gerrit-Anne Van Es, Dick Goedhart & Patrick Serruys. (2011) Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe. EuroIntervention 7:7, pages 859-871.
Crossref
T. A. Batyraliev, D. V. Fetzer, D. V. Preobrazhenskyi, A. Kochak & Yu. N. Belenkov. (2011) Middle-term results of percutaneous coronary intervention with standard metallic stent “Ephesos II” implantation in patients with coronary heart disease. Cardiovascular Therapy and Prevention 10:4, pages 63-68.
Crossref
Seiji Habara, Kazuaki Mitsudo, Kazushige Kadota, Tsuyoshi Goto, Satoki Fujii, Hiroyuki Yamamoto, Harumi Katoh, Naoki Oka, Yasushi Fuku, Shingo Hosogi, Akitoshi Hirono, Takeshi Maruo, Hiroyuki Tanaka, Yoshikazu Shigemoto, Daiji Hasegawa, Hiroshi Tasaka, Mana Kusunose, Suguru Otsuru, Yoji Okamoto, Naoki Saito & Yuki Tsujimoto. (2011) Serial Clinical and Angiographic Follow-Up After Phosphorylcholine-Coated Stent Implantation. International Heart Journal 52:2, pages 88-91.
Crossref
Laura Mauri, Joseph M. Massaro, Songtao Jiang, Ian Meredith, William Wijns, Jean Fajadet, David E. Kandzari, Martin B. Leon, Donald E. Cutlip & Kweli P. Thompson. (2010) Long-Term Clinical Outcomes With Zotarolimus-Eluting Versus Bare-Metal Coronary Stents. JACC: Cardiovascular Interventions 3:12, pages 1240-1249.
Crossref
Servaas Holvoet, Pascale Chevallier, Stéphane Turgeon & Diego Mantovani. (2010) Toward High-Performance Coatings for Biomedical Devices: Study on Plasma-Deposited Fluorocarbon Films and Ageing in PBS. Materials 3:3, pages 1515-1532.
Crossref
Ian T. Meredith, John Ormiston, Robert Whitbourn, I. Patrick Kay, David Muller & Donald E. Cutlip. (2009) Five‐year clinical follow‐up after implantation of the endeavor zotarolimus‐eluting stent: ENDEAVOR I, first‐in‐human study. Catheterization and Cardiovascular Interventions 74:7, pages 989-995.
Crossref
Bernard Chevalier, Carlo Di Mario, Franz-Josef Neumann, Flavio Ribichini, Philip Urban, Jeffrey J. Popma, Peter J. Fitzgerald, Donald E. Cutlip, David O. Williams, John Ormiston, Eberhard Grube, Robert Whitbourn & Lewis B. Schwartz. (2008) A Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zotarolimus- Versus Paclitaxel-Eluting Stents in De Novo Occlusive Lesions in Coronary Arteries. JACC: Cardiovascular Interventions 1:5, pages 524-532.
Crossref
Ian T. Meredith, John Ormiston, Robert Whitbourn, I. Patrick Kay, David Muller, Jeffrey J. Popma, Donald E. Cutlip & Peter J. Fitzgerald. (2007) Four-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, the First-in-Human Study. The American Journal of Cardiology 100:8, pages S56-S61.
Crossref
Alexandre Abizaid, Alexandra J. Lansky, Peter J. Fitzgerald, Luis Fernando Tanajura, Fausto Feres, Rodolfo Staico, Luiz Mattos, Andrea Abizaid, Aurea Chaves, Marinella Centemero, Amanda G.M.R. Sousa, J. Eduardo Sousa, Margo J. Zaugg & Lewis B. Schwartz. (2007) Percutaneous Coronary Revascularization Using a Trilayer Metal Phosphorylcholine-Coated Zotarolimus-Eluting Stent. The American Journal of Cardiology 99:10, pages 1403-1408.
Crossref
Seung Hwan Han, Tae Hoon Ahn, Woong Chol Kang, Kyu Jin Oh, Wook-Jin Chung, MI-Seung Shin, Kwang Kon Koh, In Suck Choi & Eak Kyun Shin. (2006) The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: Randomized controlled prospective study. American Heart Journal 152:5, pages 887.e1-887.e7.
Crossref
DAVID E. KANDZARI & MARTIN B. LEON. (2006) Overview of Pharmacology and Clinical Trials Program with the Zotarolimus-Eluting Endeavor Stent. Journal of Interventional Cardiology 19:5, pages 405-413.
Crossref
Jean FajadetWilliam WijnsGert-Jan LaarmanKarl-Heinz KuckJohn OrmistonThomas MünzelJeffrey J. PopmaPeter J. FitzgeraldRaoul BonanRichard E. Kuntz. (2006) Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions. Circulation 114:8, pages 798-806.
Crossref
Christoph Strehblow, Wolfgang Sperker, Akos Hevesi, Rita Garamvölgyi, Zsolt Petrasi, Maryam Shirazi, Christer Sylvén, Thomas Weiss, Chaim Lotan, Thea Pugatsch, Shmuel A. Ben-Sasson, Michael Orlowski, Dietmar Glogar & Mariann Gyöngyösi. (2006) Paradoxical Effects of Aurintricarboxylic Acid and RG-13577 : Acute Thrombosis and In-Stent Stenosis in a Passive-Coated Stent . Journal of Endovascular Therapy 13:1, pages 94-103.
Crossref
A. Bakhai, J. Booth, N. Delahunty, F. Nugara, T. Clayton, J. McNeill, S.W. Davies, D.C. Cumberland & R.H. Stables. (2005) The SV stent study: a prospective, multicentre, angiographic evaluation of the BiodivYsio phosphorylcholine coated small vessel stent in small coronary vessels. International Journal of Cardiology 102:1, pages 95-102.
Crossref
Robin Collingwood, Lori Gibson, Souad Sedlik, Renu Virmani & Andrew J. Carter. (2005) Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. Catheterization and Cardiovascular Interventions 65:2, pages 227-232.
Crossref
Thomas W. JohnsonYin Xiong WuChristian HerdegAndreas BaumbachAndrew C. NewbyKarl R. KarschMartin Oberhoff. (2005) Stent-Based Delivery of Tissue Inhibitor of Metalloproteinase-3 Adenovirus Inhibits Neointimal Formation in Porcine Coronary Arteries. Arteriosclerosis, Thrombosis, and Vascular Biology 25:4, pages 754-759.
Crossref
Goetz M. Richter, Ulrike Stampfl, Sibylle Stampfl, Christoph Rehnitz, Susann Holler, Philip Schnabel & Michael Grunze. (2005) A New Polymer Concept for Coating of Vascular Stents Using PTFEP (poly(bis(trifluoroethoxy)phosphazene) to Reduce Thrombogenicity and Late In-Stent Stenosis. Investigative Radiology 40:4, pages 210-218.
Crossref
Norihiko Shinozaki, Hiroyoshi Yokoi, Masashi Iwabuchi, Hideyuki Nosaka, Kazushige Kadota, Kazuaki Mitsudo & Masakiyo Nobuyoshi. (2005) Initial and Follow-up Results of the BiodivYsio Phosphorylcholine Coated Stent for Treatment of Coronary Artery Disease. Circulation Journal 69:3, pages 295-300.
Crossref
Nick E.J. WestPeter N. RuygrokClemens M.C. DiscoMark W.I. WebsterWietze K. LindeboomWilliam W. O’NeillNestor F. MercadoPatrick W. Serruys. (2004) Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients. Circulation 109:7, pages 867-873.
Crossref
Flavio Airoldi, Antonio Colombo, Davide Tavano, Goran Stankovic, Silvio Klugmann, Vito Paolillo, Erminio Bonizzoni, Carlo Briguori, Mauro Carlino, Matteo Montorfano, Francesco Liistro, Alfredo Castelli, Angela Ferrari, Fabio Sgura & Carlo Di Mario. (2004) Comparison of diamond-like carbon-coated stents versus uncoated stainless steel stents in coronary artery disease. The American Journal of Cardiology 93:4, pages 474-477.
Crossref
Igor Pershukov, Talantbek Batyraliev, Anatolii Samko, Yuri Belenkov, Zalema Niyazova-Karben & Oleg Calenici. (2004) In-hospital, six - and eighteen month's results of Ephesos coronary stent implantation in patients with unstable or stable angina. Electronic Journal of General Medicine 1:1, pages 19-25.
Crossref
Xiaoshun Liu, Yanming Huang, Claude Hanet, Michel Vandormael, Victor Legrand, Joseph Dens, Jean Luc Vandenbossche, Luc Missault, Christiaan Vrints & Ivan De Scheerder. (2003) Study of antirestenosis with the BiodivYsio dexamethasone‐eluting stent (STRIDE): A first‐in‐human multicenter pilot trial. Catheterization and Cardiovascular Interventions 60:2, pages 172-178.
Crossref
I. A. Karoussos, H. Wieneke, T. Sawitowski, S. Wnendt, A. Fischer, O. Dirsch, U. Dahmen & R. Erbel. (2003) Inorganic materials as drug delivery systems in coronary artery stenting. Materialwissenschaft und Werkstofftechnik 33:12, pages 738-746.
Crossref
David E. Kandzari, James E. Tcheng & James P. Zidar. (2002) Coronary artery stents: Evaluating new designs for contemporary percutaneous intervention. Catheterization and Cardiovascular Interventions 56:4, pages 562-576.
Crossref
Hélène Eltchaninoff, Rémi Pillière, Gilles Traisnel, Jacques Berland, Simon Cattan, Jacques Monségu & Alain Cribier. (2002) Acute and six-month clinical outcome after Helistent stent implantation in coronary arteries: Results of the French Helistent multicenter registry. Catheterization and Cardiovascular Interventions 56:3, pages 295-299.
Crossref
A.L. Lewis, L.A. Tolhurst & P.W. Stratford. (2002) Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation. Biomaterials 23:7, pages 1697-1706.
Crossref
A. L. Lewis, J. D. Furze, S. Small, J. D. Robertson, B. J. Higgins, S. Taylor & D. R. Ricci. (2002) Long-term stability of a coronary stent coating post-implantation. Journal of Biomedical Materials Research 63:6, pages 699-705.
Crossref
Peter N. RuygrokMark W.I. WebsterVincent de ValkGerrit-Anne van EsJohn A. OrmistonMarie-Angèle M. MorelPatrick W. Serruys. (2001) Clinical and Angiographic Factors Associated With Asymptomatic Restenosis After Percutaneous Coronary Intervention. Circulation 104:19, pages 2289-2294.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.